Eric Eldering

8.3k citations
170 papers · 6.2k · h-index 46

Impact in

  • Genetics top 0.1%
    • Chronic Lymphocytic Leukemia Research
    • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Immunology top 0.5%
    • Immune Cell Function and Interaction
    • Immunodeficiency and Autoimmune Disorders
    • T-cell and B-cell Immunology

Papers in

  • Genetics 115
    • Chronic Lymphocytic Leukemia Research 102
  • Immunology 65
    • Immune Cell Function and Interaction 25
    • Immunodeficiency and Autoimmune Disorders 23
Co-authors
Arnon P. Kater (85 shared papers)René A. W. van Lier (26 shared papers)Marinus H. J. van Oers (38 shared papers)Ingrid A. M. Derks (22 shared papers)Marcel Spaargaren (14 shared papers)Steven T. Pals (6 shared papers)Carel J.M. van Noesel (7 shared papers)Christian R. Geest (5 shared papers)
Journals
Blood (48 papers)Leukemia (11 papers)Journal of Biological Chemistry (8 papers)The Journal of Immunology (7 papers)Haematologica (6 papers)
Partner nations
NetherlandsUnited StatesUnited Kingdom

In The Last Decade

Eric Eldering

170 papers receiving 6.1k citations

Peers

Eric Eldering
Comparison fields: 5 of 110
  • Genetics 2.5k
  • Immunology 2.3k
  • Hematology 960
  • Pathology and Forensic Medicine 1.2k
  • Oncology 1.5k
Replace R. Eric Davis with:
R. Eric Davis United States
Beatríz Bellosillo Spain
David Spaner Canada
Shinsuke Iida Japan
Kamal D. Puri United States
Marcel Spaargaren Netherlands
Selina Chen‐Kiang United States
Bruno Quesnel France
Luc Xerri France
Javier Pinilla‐Ibarz United States
Eric Eldering relative to R. Eric Davis United States R. Eric Davis's profile →
Citations per field
00.5×1.5×
R. Eric Davis · 1×
Citations per year

Countries citing papers authored by Eric Eldering

Since Specialization
Citations

This map shows the geographic impact of Eric Eldering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Eldering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Eldering more than expected).

Fields of papers citing papers by Eric Eldering

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Eldering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Eldering. The network helps show where Eric Eldering may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric Eldering, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric Eldering Line = papers co-authored together Eric Eldering links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 170 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor– and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia
Blood ·Martin F. M. de Rooij, Annemieke Kuil, Christian R. Geest, Eric Eldering, Betty Chang, Joseph J. Buggy, Steven T. Pals, Marcel Spaargaren
2012417
2
CD20 deficiency in humans results in impaired T cell–independent antibody responses
Journal of Clinical Investigation ·Taco W. Kuijpers, Richard J. Bende, Paul A. Baars, Annette Grummels, Ingrid A. M. Derks, Koert M. Dolman, Tim Beaumont, Thomas F. Tedder, Carel J.M. van Noesel, Eric Eldering, René A. W. van Lier
2009283
3
miR-34a as part of the resistance network in chronic lymphocytic leukemia
Blood ·Thorsten Zenz, Julia Mohr, Eric Eldering, Arnon P. Kater, Andreas Bühler, Dirk Kienle, Dirk Winkler, Jan Dürig, Marinus H. J. van Oers, Daniel Mertens, Hartmut Döhner, Stephan Stilgenbauer
2008216
4
Histone Deacetylase Inhibitors Suppress Inflammatory Activation of Rheumatoid Arthritis Patient Synovial Macrophages and Tissue
The Journal of Immunology ·Aleksander M. Grabiec, Sarah Krausz, Wilco de Jager, Tomasz Burakowski, Dion Groot, M. Sanders, Berent J. Prakken, Włodzimierz Maśliński, Eric Eldering, Paul P. Tak, Kris A. Reedquist
2010193
5
The Noxa/Mcl-1 Axis Regulates Susceptibility to Apoptosis under Glucose Limitation in Dividing T Cells
Immunity ·Nuno L. Alves, Ingrid A. M. Derks, Erik Berk, René Spijker, René A. W. van Lier, Eric Eldering
2006158
6
Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways
Nucleic Acids Research ·Eric Eldering
2003142
7
Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy
Blood ·Jaco A. C. van Bruggen, Anne W. J. Martens, Joseph A. Fraietta, Tom Hofland, Sanne H. Tonino, Eric Eldering, Mark‐David Levin, Peter J. Siska, Sanne Endstra, Jeffrey C. Rathmell, Carl H. June, David L. Porter, J. Joseph Melenhorst, Arnon P. Kater, Gerritje J. W. van der Windt
2019142
8
Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity
Blood ·Laura A. Smit, Delfine Y.H. Hallaert, René Spijker, Bart E.C.G. de Goeij, Annelieke Jaspers, Arnon P. Kater, Marinus H. J. van Oers, Carel J.M. van Noesel, Eric Eldering
2006134
9
APRIL promotes B-1 cell-associated neoplasm
Cancer Cell ·Lourdes Planelles, Carla Eponina Carvalho-Pinto, Gijs Hardenberg, Salete Smaniotto, Wilson Savino, Ruth Gómez-Caro, Melchor Álvarez‐Mon, Joan de Jong, Eric Eldering, Carlos Martínez‐A, Jan Paul Medema, Michael Hahne
2004124
10
Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma
The Journal of Immunology ·Walter A. Wuillemin, Henk te Velthuis, Yvonne T.P. Lubbers, Cornelis P. de Ruig, Eric Eldering, C.E. Hack
1997115
11
The Costimulatory Molecule CD27 Maintains Clonally Diverse CD8+ T Cell Responses of Low Antigen Affinity to Protect against Viral Variants
Immunity ·Klaas P. J. M. van Gisbergen, Paul L. Klarenbeek, Natasja A. M. Kragten, Peter‐Paul A. Unger, Marieke B.B. Nieuwenhuis, Felix M. Wensveen, Anja ten Brinke, Paul P. Tak, Eric Eldering, Martijn A. Nolte, René A. W. van Lier
2011110
12
IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells
Blood ·María Fernanda Pascutti, Margot Jak, Jacqueline M. Tromp, Ingrid A. M. Derks, Ester B. M. Remmerswaal, Rachel Thijssen, Martijn H.A. van Attekum, Gregor G. van Bochove, Dieuwertje M. Luijks, Steven T. Pals, René A. W. van Lier, Arnon P. Kater, Marinus H. J. van Oers, Eric Eldering
2013108
13
A hinge region mutation in C1-inhibitor (Ala436–>Thr) results in nonsubstrate-like behavior and in polymerization of the molecule.
Journal of Biological Chemistry ·Kulwant S. Aulak, Eric Eldering, C. Erik Hack, Y.P. Lubbers, R. A. Harrison, Alan E. Mast, Marco Cicardi, Alvin E. Davis
1993106
14
CD27-CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell development
International Immunology ·Michiel F. van Oosterwijk, Hedy Juwana, Ramon Arens, Kiki Tesselaar, Marinus H. J. van Oers, Eric Eldering, René A. W. van Lier
2007106
15
c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches
Blood ·Delfine Y.H. Hallaert, Annelieke Jaspers, Carel J.M. van Noesel, Marinus H. J. van Oers, Arnon P. Kater, Eric Eldering
2008101
16
Enhanced formation and survival of CD4+CD25hiFoxp3+T-cells in chronic lymphocytic leukemia
Leukemia & lymphoma ·Margot Jak, Rogier Mous, Ester B. M. Remmerswaal, René Spijker, Annelieke Jaspers, Adriana Yagüe, Eric Eldering, René A. W. van Lier, Marinus H. J. van Oers
200994
17
COOH-terminal Substitutions in the Serpin C1 Inhibitor That Cause Loop Overinsertion and Subsequent Multimerization
Journal of Biological Chemistry ·Dorina Roem, Eric Eldering, Elisabeth Verpy, Tommaso Meo, Mario Tosi
199593
18
Modulation of Contact System Proteases by Glycosaminoglycans
Journal of Biological Chemistry ·Walter A. Wuillemin, Eric Eldering, Franca Citarella, Cornelis P. de Ruig, Hugo Ten Cate, C. Erik Hack
199690
19
Blimp‐1 homolog Hobit identifies effector‐type lymphocytes in humans
European Journal of Immunology ·Felipe A. Vieira Braga, Kirsten M. L. Hertoghs, Natasja A. M. Kragten, Gina M. Doody, Nicholas A. Barnes, Ester B. M. Remmerswaal, Cheng‐Chih Hsiao, Perry D. Moerland, Diana Wouters, Ingrid A. M. Derks, Amber van Stijn, Marc Demkes, Jörg Hamann, Eric Eldering, Martijn A. Nolte, Reuben Tooze, Ineke J. M. ten Berge, Klaas P. J. M. van Gisbergen, René A. W. van Lier
201586
20
Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment
Blood Advances ·Iris de Weerdt, Tom Hofland, Renate de Boer, Johan A. Dobber, Julie Dubois, Denise van Nieuwenhuize, Mehrdad Mobasher, Fransien de Boer, Mels Hoogendoorn, Gerjo A. Velders, Marjolein van der Klift, Ester B. M. Remmerswaal, Fréderike J. Bemelman, Carsten Utoft Niemann, Sabina Kersting, Mark‐David Levin, Eric Eldering, Sanne H. Tonino, Arnon P. Kater
201980

About Eric Eldering

Eric Eldering is a scholar working on Genetics, Immunology, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 170 papers that have together received 6.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (102 papers), Lymphoma Diagnosis and Treatment (31 papers), Immune Cell Function and Interaction (25 papers), Immunodeficiency and Autoimmune Disorders (23 papers), Cell death mechanisms and regulation (20 papers), Chronic Myeloid Leukemia Treatments (17 papers), CAR-T cell therapy research (16 papers) and Acute Lymphoblastic Leukemia research (14 papers). The work is most often cited by research in Genetics (2.5k citations), Immunology (2.3k citations), Hematology (960 citations), Pathology and Forensic Medicine (1.2k citations) and Oncology (1.5k citations). Eric Eldering has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Arnon P. Kater, René A. W. van Lier, Marinus H. J. van Oers, Ingrid A. M. Derks, Marcel Spaargaren, Steven T. Pals, Carel J.M. van Noesel, Christian R. Geest, Annelieke Jaspers and Martin F. M. de Rooij. Their work appears in journals such as Blood, Leukemia, Journal of Biological Chemistry, The Journal of Immunology and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Eric DavisBreakdown of academic impact, for papers by Beatríz BellosilloBreakdown of academic impact, for papers by David SpanerBreakdown of academic impact, for papers by Shinsuke IidaBreakdown of academic impact, for papers by Kamal D. PuriBreakdown of academic impact, for papers by Marcel SpaargarenBreakdown of academic impact, for papers by Selina Chen‐KiangBreakdown of academic impact, for papers by Bruno QuesnelBreakdown of academic impact, for papers by Luc XerriBreakdown of academic impact, for papers by Javier Pinilla‐Ibarz